PubMed

Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells.

Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ.

Cancer Res. 2003 Apr 15;63(8):1764-8.PMID: 12702559 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer.

Kohli M, Kaushal V, Spencer HJ, Mehta P.

Urology. 2003 Apr;61(4):765-9.PMID: 12670562 [PubMed - indexed for MEDLINE]Related articles

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.

Drake MJ, Robson W, Mehta P, Schofield I, Neal DE, Leung HY.

Br J Cancer. 2003 Mar 24;88(6):822-7.PMID: 12644816 [PubMed - indexed for MEDLINE]Related articlesFree article

Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ.

Clin Cancer Res. 2003 Mar;9(3):1200-10.PMID: 12631626 [PubMed - indexed for MEDLINE]Related articlesFree article

[Gene expression profiles of protein kinases and phosphatases obtained by hybridization with cDNA arrays: molecular portrait of human prostate carcinoma]

Kniazev IuP, Cheburkin IuV, Spikermann K, Peter S, Jenster G, Bangma KH, Karelin MI, Shkol'nik MI, Urbanskiĭ AI, Evtushenko VI, Ullrich A, Kniazev PG.

Mol Biol (Mosk). 2003 Jan-Feb;37(1):97-111. Russian. PMID: 12624952 [PubMed - indexed for MEDLINE]Related articles

Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?

Burroughs KD, Oh J, Barrett JC, DiAugustine RP.

Mol Cancer Res. 2003 Feb;1(4):312-22.PMID: 12612059 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of angiogenesis in prostate development and the pathogenesis of prostate cancer.

Hrouda D, Nicol DL, Gardiner RA.

Urol Res. 2003 Feb;30(6):347-55. Epub 2002 Nov 21. Review.PMID: 12599013 [PubMed - indexed for MEDLINE]Related articles

Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer.

Shigeno K, Igawa M, Shiina H, Kishi H, Urakami S.

BJU Int. 2003 Feb;91(3):223-6.PMID: 12581009 [PubMed - indexed for MEDLINE]Related articles

Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2.

Keledjian K, Kyprianou N.

J Urol. 2003 Mar;169(3):1150-6.PMID: 12576871 [PubMed - indexed for MEDLINE]Related articles

Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants.

Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, Somlyo AP.

FASEB J. 2003 Feb;17(2):223-34.PMID: 12554701 [PubMed - indexed for MEDLINE]Related articlesFree article

Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.

Yin YJ, Salah Z, Maoz M, Ram SC, Ochayon S, Neufeld G, Katzav S, Bar-Shavit R.

FASEB J. 2003 Feb;17(2):163-74.PMID: 12554695 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlates of thrombin generation in patients with advanced prostate cancer.

Lind SE, Caprini JA, Goldshteyn S, Dohnal JC, Vesely SK, Shevrin DH.

Thromb Haemost. 2003 Jan;89(1):185-9.PMID: 12540969 [PubMed - indexed for MEDLINE]Related articles

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

Letsch M, Schally AV, Busto R, Bajo AM, Varga JL.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1250-5. Epub 2003 Jan 21.PMID: 12538852 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470.

Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PE.

Clin Cancer Res. 2003 Jan;9(1):355-62.PMID: 12538488 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer.

Dall'Era MA, Shih SJ, Yang J, Benik S, Gandour-Edwards R, Evans CP.

Prostate Cancer Prostatic Dis. 2001;4(2):106-111.PMID: 12497047 [PubMed - as supplied by publisher]Related articlesFree article

Distribution of vascular endothelial growth factor (VEGF) in prostate disease.

Walsh K, Sriprasad S, Hopster D, Codd J, Mulvin D.

Prostate Cancer Prostatic Dis. 2002;5(2):119-22.PMID: 12497000 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.

Becker CM, Farnebo FA, Iordanescu I, Behonick DJ, Shih MC, Dunning P, Christofferson R, Mulligan RC, Taylor GA, Kuo CJ, Zetter BR.

Cancer Biol Ther. 2002 Sep-Oct;1(5):548-53.PMID: 12496487 [PubMed - indexed for MEDLINE]Related articles

[The inhibitory action of the antisense oligodeoxynucleotide to the expression of vascular endothelial growth factor by radiotherapy in a prostate cancer cell line]

Meng DY, Xue WC, Hu XF, Wang YN, Luo J.

Zhonghua Nan Ke Xue. 2002;8(2):95-7. Chinese. PMID: 12479018 [PubMed - indexed for MEDLINE]Related articles

New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.

Curran WJ.

Oncology. 2002;63 Suppl 2:29-38. Review.PMID: 12466642 [PubMed - indexed for MEDLINE]Related articles

[Anti-angiogenic drugs probable complement in cancer therapy]

Christofferson R, Claesson-Welsh L, Muhr C.

Lakartidningen. 2002 Oct 17;99(42):4138-9, 4142-8. Review. Swedish. PMID: 12448292 [PubMed - indexed for MEDLINE]Related articles